These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 24178246)

  • 21. Cystic fibrosis and the role of gastrointestinal outcome measures in the new era of therapeutic CFTR modulation.
    Bodewes FA; Verkade HJ; Taminiau JA; Borowitz D; Wilschanski M;
    J Cyst Fibros; 2015 Mar; 14(2):169-77. PubMed ID: 25677689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Role of provisionally pathogenic microbial flora in the genesis of gastrointestinal diseases in young children. A review of the literature].
    Goshovatiuk NK
    Pediatr Akus Ginekol; 1973; 2():19-22. PubMed ID: 4597685
    [No Abstract]   [Full Text] [Related]  

  • 23. Development of the gut microbiota in early life: The impact of cystic fibrosis and antibiotic treatment.
    Kristensen M; Prevaes SMPJ; Kalkman G; Tramper-Stranders GA; Hasrat R; de Winter-de Groot KM; Janssens HM; Tiddens HA; van Westreenen M; Sanders EAM; Arets B; Keijser B; van der Ent CK; Bogaert D
    J Cyst Fibros; 2020 Jul; 19(4):553-561. PubMed ID: 32487494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gut dysbiosis in cystic fibrosis.
    Scanlan PD; Buckling A; Kong W; Wild Y; Lynch SV; Harrison F
    J Cyst Fibros; 2012 Sep; 11(5):454-5. PubMed ID: 22538067
    [No Abstract]   [Full Text] [Related]  

  • 25. Altered intestinal microbiota composition, antibiotic therapy and intestinal inflammation in children and adolescents with cystic fibrosis.
    de Freitas MB; Moreira EAM; Tomio C; Moreno YMF; Daltoe FP; Barbosa E; Ludwig Neto N; Buccigrossi V; Guarino A
    PLoS One; 2018; 13(6):e0198457. PubMed ID: 29933382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Enigmatic Gut in Cystic Fibrosis: Linking Inflammation, Dysbiosis, and the Increased Risk of Malignancy.
    Garg M; Ooi CY
    Curr Gastroenterol Rep; 2017 Feb; 19(2):6. PubMed ID: 28155088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of Clostridium perfringens, Clostridium perfringens enterotoxin and dysbiosis in fecal samples of dogs with diarrhea.
    Minamoto Y; Dhanani N; Markel ME; Steiner JM; Suchodolski JS
    Vet Microbiol; 2014 Dec; 174(3-4):463-473. PubMed ID: 25458422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cystic fibrosis: gastrointestinal complications.
    Littlewood JM
    Br Med Bull; 1992 Oct; 48(4):847-59. PubMed ID: 1458304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct assessment of gastrointestinal inflammation and mucosal immunity in children with cystic fibrosis.
    Croft NM; Marshall TG; Ferguson A
    Postgrad Med J; 1996 Mar; 72 Suppl 2():S32-6. PubMed ID: 8869180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gut microbiota signatures in cystic fibrosis: Loss of host CFTR function drives the microbiota enterophenotype.
    Vernocchi P; Del Chierico F; Russo A; Majo F; Rossitto M; Valerio M; Casadei L; La Storia A; De Filippis F; Rizzo C; Manetti C; Paci P; Ercolini D; Marini F; Fiscarelli EV; Dallapiccola B; Lucidi V; Miccheli A; Putignani L
    PLoS One; 2018; 13(12):e0208171. PubMed ID: 30521551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic accuracy of fecal elastase 1 assay in patients with pancreatic maldigestion or intestinal malabsorption: a collaborative study of the Italian Society of Pediatric Gastroenterology and Hepatology.
    Carroccio A; Verghi F; Santini B; Lucidi V; Iacono G; Cavataio F; Soresi M; Ansaldi N; Castro M; Montalto G
    Dig Dis Sci; 2001 Jun; 46(6):1335-42. PubMed ID: 11414313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Probiotic supplementation in children with cystic fibrosis-a systematic review.
    Ananthan A; Balasubramanian H; Rao S; Patole S
    Eur J Pediatr; 2016 Oct; 175(10):1255-66. PubMed ID: 27576473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated fecal M2-pyruvate kinase in children with cystic fibrosis: a clue to the increased risk of intestinal malignancy in adulthood?
    Pang T; Leach ST; Katz T; Jaffe A; Day AS; Ooi CY
    J Gastroenterol Hepatol; 2015 May; 30(5):866-71. PubMed ID: 25376228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cystic fibrosis transmembrane conductance regulator (CFTR) allelic variants relate to shifts in faecal microbiota of cystic fibrosis patients.
    Schippa S; Iebba V; Santangelo F; Gagliardi A; De Biase RV; Stamato A; Bertasi S; Lucarelli M; Conte MP; Quattrucci S
    PLoS One; 2013; 8(4):e61176. PubMed ID: 23613805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CFTR dysregulation drives active selection of the gut microbiome.
    Meeker SM; Mears KS; Sangwan N; Brittnacher MJ; Weiss EJ; Treuting PM; Tolley N; Pope CE; Hager KR; Vo AT; Paik J; Frevert CW; Hayden HS; Hoffman LR; Miller SI; Hajjar AM
    PLoS Pathog; 2020 Jan; 16(1):e1008251. PubMed ID: 31961914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of CFTR modulation with Ivacaftor on Gut Microbiota and Intestinal Inflammation.
    Ooi CY; Syed SA; Rossi L; Garg M; Needham B; Avolio J; Young K; Surette MG; Gonska T
    Sci Rep; 2018 Dec; 8(1):17834. PubMed ID: 30546102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beyond pancreatic insufficiency and liver disease in cystic fibrosis.
    Demeyer S; De Boeck K; Witters P; Cosaert K
    Eur J Pediatr; 2016 Jul; 175(7):881-94. PubMed ID: 27055450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Summary of Normal Development of Gut Microbiota and Dysbiosis.
    Isolauri E
    Nestle Nutr Inst Workshop Ser; 2017; 88():127-128. PubMed ID: 28346929
    [No Abstract]   [Full Text] [Related]  

  • 39. Cystic fibrosis. Gastrointestinal complications and gene therapy.
    Shalon LB; Adelson JW
    Pediatr Clin North Am; 1996 Feb; 43(1):157-96. PubMed ID: 8596679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The frequency of detection, typical composition and sensitivity to coli-protein bacteriophage of enteropathogenic Escherichia coli isolated from young children with various gastrointestinal diseases from 1959 to 1965].
    Garanin BA
    Zh Mikrobiol Epidemiol Immunobiol; 1968 Nov; 45(11):150-1. PubMed ID: 4898175
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.